Gyrus Acquisition Of Everest Medical Offers British Firm Viable U.S. Presence
This article was originally published in The Gray Sheet
Executive Summary
Everest Medical will provide a direct channel to the U.S. for UK-based Gyrus Group's PlasmaKinetic II (PK II) radiofrequency electrosurgery products. The proposed $52 mil. acquisition was announced Feb. 23.